HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Companyâs novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patientâs heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
äŒæ¥ã³ãŒãHTFL
äŒç€ŸåHeartflow Inc
äžå Žæ¥Aug 08, 2025
æé«çµå¶è²¬ä»»è
ãCEOãFarquhar (John C. M)
åŸæ¥å¡æ°699
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Aug 08
æ¬ç€Ÿæåšå°331 E Evelyn Avenue
éœåžMOUNTAIN VIEW
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94041
é»è©±çªå·16502411221
ãŠã§ããµã€ãhttps://www.heartflow.com/
äŒæ¥ã³ãŒãHTFL
äžå Žæ¥Aug 08, 2025
æé«çµå¶è²¬ä»»è
ãCEOãFarquhar (John C. M)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã